Concepedia

High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdrawal

Peter Bartenstein, Elisa Caballero Calabuig, C.L. Maini, Renzo Mazzarotto, M.A. Muros de Fuentes, T. Petrich, Fernando Rodrigues, Juan Antonio Vallejo Casas, Federica Vianello, Michela Basso,

Thyroid · 2013 · 28 citations · 14 references

DOI

Abstract

Use of rhTSH as preparation for thyroid remnant ablation in patients with T4 primary tumors achieved a rate of ablation success that was high and noninferior to the rate seen after THW, and rhTSH was well tolerated.

References

14

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

Martin Schlumberger, Bogdan Catargi, Isabelle Borget et al. · New England Journal of Medicine · 2012 · 681 citations · Full text

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

Ujjal K. Mallick, Clive Harmer, B. Yap et al. · New England Journal of Medicine · 2012 · 606 citations · Full text

Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma

Paul W. Ladenson, Lewis E. Braverman, Ernest L. Mazzaferri et al. · New England Journal of Medicine · 1997 · 469 citations · Full text

Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study

Furio Pacini, P. W. Ladenson, Martin Schlumberger et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 447 citations

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.

Heribert Hänscheid, Markus Luster, Stephen R. Thomas et al. · PubMed · 2006 · 333 citations